Therefore, RNA interference (RNAi) targeting of Cdk5 reduces tau phosphorylation and decreases the number of neurofibrillary tangles in the hippocampus of triple-transgenic Alzheimer’s disease (AD) mice35. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.